Interferon β-1a in ulcerative colitis: a placebo controlled, randomised, dose escalating study

Background and aims: Administration of interferon (IFN)-β may represent a rational approach to the treatment of ulcerative colitis through its immunomodulatory and anti-inflammatory effects. The present study was performed to evaluate the efficacy and tolerability of IFN-β-1a. Methods: Patients (n=1...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Nikolaus, S, Rutgeerts, P, Fedorak, R, Steinhart, A H, Wild, G E, Theuer, D, Möhrle, J, Schreiber, S
Format: Artigo
Sprache:Inglês
Veröffentlicht: Copyright 2003 by Gut 2003
Schlagworte:
Inflammatory Bowel Disease
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1773804/
https://ncbi.nlm.nih.gov/pubmed/12912859
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge